EICHORPublic-registry site landscape for NCT06016972, “Qlaris Phase 2 Study of QLS-111 in POAG And/or OHT Patients”, a Primary Open Angle Glaucoma (POAG) study sponsored by Qlaris Bio, Inc.. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT06016972 (registry record) |
| Study title | Qlaris Phase 2 Study of QLS-111 in POAG And/or OHT Patients |
| Official title | A Randomized, Multi-site, Double-masked Study Evaluating the Safety and Tolerability of QLS-111 Vs Vehicle in Primary Open-angle Glaucoma or Ocular Hypertension Patients |
| Sponsor | Qlaris Bio, Inc. |
| Condition(s) | Primary Open Angle Glaucoma (POAG); Primary Open Angle Glaucoma of Both Eyes; Primary Open-Angle Glaucoma, Unspecified Eye; Ocular Hypertension (OHT) |
| Phase | PHASE2 |
| Listed sites | 1 |
| Site countries | United States |
Patient-friendly overview of this study: eichor.com/study/NCT06016972.
Eichor generates a preliminary site-risk snapshot for NCT06016972 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →
Other Primary Open Angle Glaucoma (POAG) trials
← Eichor home · All tracked trials · Primary Open Angle Glaucoma (POAG) studies · Weekly briefs
